Skip to main content
Premium Trial:

Request an Annual Quote

Whatman to Provide DNA Collection Kits to PGx Study of Prostate Cancer

NEW YORK (GenomeWeb News) — Whatman today said it will provide DNA collection kits based on its FTA elute technology to an international prostate cancer pharmacogenotyping study that aims to uncover links between SNPs and drug efficacy, side-effects, or individual susceptibility to prostate cancer.
The study is part of the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy trial, also known as STAMPEDE.
STAMPEDE is a multi-stage randomized controlled trial for around 3,300 patients with newly diagnosed advanced prostate cancer or for patients with a rapid PSA rise following previous surgery or radiotherapy.
The sub study is designed to study the metabolic pathways by which androgen blocking drugs affect patients, and to examine how genes affect drugs by comparing the response to one of six treatment combinations.
Each of the patients will have the option to contribute a sample of genetic material using the Whatman FTA Elute kit, which uses a chemically treated matrix that lyses cells and immobilizes nucleic acids on contact, enabling scientists to collect, transport, archive, and isolate DNA and RNA samples at room temperature in a single step.
Next, the sub study will isolate small sections of the DNA to identify SNP biomarkers that differentiate how patients may respond to a given therapy. “Researchers hope to uncover links between certain SNPs and drug efficacy, side-effects, or individual susceptibility to prostate cancer,” Whatman said in a statement.
The study is being conducted through the UK Medical Research Council Clinical Trials Unit in London and the University of Birmingham. It is sponsored by the British Medical Research Council, funded by Cancer Research UK, and supported by the National Cancer Research Institute and National Cancer Research Network.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.